The Finasteride Riddle

    Stewart Justman
    TLDR Finasteride reduces low-grade prostate cancer but may not be beneficial overall.
    The study on finasteride, originally aimed at reducing prostate cancer incidence, revealed a paradox: it decreased low-grade prostate cancer but seemingly increased high-grade disease. Due to these mixed outcomes, the FDA did not approve finasteride for cancer prevention. Follow-up data suggested that concerns about finasteride's risks might have been overstated, yet it did not demonstrate a reduction in mortality. Although finasteride could potentially aid in reducing overdiagnosis in PSA testing, other associated harms questioned its utility even in this secondary role.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    1 / 1 results